These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25753003)

  • 1. Non-drug-induced Stevens-Johnson syndrome successfully treated with high-dose i.v. immunoglobulin.
    Nozaki Y; Fujita H; Okada R; Kou K; Aihara M
    J Dermatol; 2015 Apr; 42(4):439-40. PubMed ID: 25753003
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic epidermal necrolysis in a 4-year-old boy successfully treated with plasma exchange in combination with methylprednisolone and i.v. immunoglobulin.
    Aihara Y; Oyama Y; Ichikawa K; Takeshita S; Takahashi Y; Kambara T; Aihara M
    J Dermatol; 2012 Nov; 39(11):951-2. PubMed ID: 22414294
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of intravenous high-dose immunoglobulins (IGIV) in a case of Stevens-Johnson syndrome].
    Amato GM; Travia A; Ziino O
    Pediatr Med Chir; 1992; 14(5):555-6. PubMed ID: 1488317
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins.
    Tan A; Tan HH; Lee CC; Ng SK
    Clin Exp Dermatol; 2003 May; 28(3):269-71. PubMed ID: 12780710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis in children: Report of two cases secondary to anticonvulsants.
    Romero-Tapia SJ; Cámara-Combaluzier HH; Baeza-Bacab MA; Cerino-Javier R; Bulnes-Mendizabal DP; Virgen-Ortega C
    Allergol Immunopathol (Madr); 2015; 43(2):227-9. PubMed ID: 25183634
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin prophylaxis for recurrent Stevens-Johnson syndrome.
    Hebert AA; Bogle MA
    J Am Acad Dermatol; 2004 Feb; 50(2):286-8. PubMed ID: 14726889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 8. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome.
    Vázquez-Sanabria IL; Mercado-Seda R; Varela-Rosario N; Vilá LM
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26202316
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxic epidermal necrolysis as a complication of treatment with voriconazole.
    Huang DB; Wu JJ; Lahart CJ
    South Med J; 2004 Nov; 97(11):1116-7. PubMed ID: 15586606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JK; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KM; Wong GA; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    Br J Dermatol; 2016 Jun; 174(6):1194-227. PubMed ID: 27317286
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl.
    Dang CD; Beets-Shay L; Kahn EC
    Pediatr Dermatol; 2015; 32(3):e102-3. PubMed ID: 25690725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins.
    Paquet P; Jacob E; Damas P; Piérard GE
    Burns; 2001 Sep; 27(6):652-5. PubMed ID: 11525863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy for children with Stevens-Johnson syndrome.
    Morici MV; Galen WK; Shetty AK; Lebouef RP; Gouri TP; Cowan GS; Gedalia A
    J Rheumatol; 2000 Oct; 27(10):2494-7. PubMed ID: 11036849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
    Hung PC; Wang HS; Hsia SH; Wong AM
    Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of intravenous immunoglobulin in toxic epidermal necrolysis.
    Feldmeyer L; Kerdel FA; French LE
    Arch Dermatol; 2011 Dec; 147(12):1440-1. PubMed ID: 22184768
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
    Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
    Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.